Pear Therapeutics Announces First Patient Dosed in Part II of Pear-006 Feasibility Study to Treat Depressive Symptoms in People with Multiple Sclerosis
Pear Therapeutics, Inc. today announced the first patient dosed in part II of the first…
Arboretum_JDDecember 17, 2019